As described above, another limitation was the lack of any mechanistic insight into how A2AR enhances anti-tumor immunity and the mechanism of suppressing T cell immunity through extracellular adenosine production and after binding to A2AR. This evidence concerns the gene ADORA2A and neoplasm.